Anti-dementia medications: current prescriptions in clinical practice and new agents in progress

Imagem de Miniatura
Arquivos
art_STELLA_Antidementia_medications_current_prescriptions_in_clinical_practice_and_2015.PDF (720.35 KB)
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2015
Editora
SAGE PUBLICATIONS LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
THERAPEUTIC ADVANCES IN DRUG SAFETY, v.6, n.4, p.151-165, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Almost three decades after the publication of the first clinical studies with tacrine, the pharmacological treatment of Alzheimer's disease (AD) remains a challenge. Randomized clinical trials have yielded evidence of significant - although modest and transient - benefit from cholinergic replacement therapy for people diagnosed with AD, and disease modification with antidementia compounds is still an urgent, unmet need. The natural history of AD is very long, and its pharmacological treatment must acknowledge different needs according to the stage of the disease process. Cognitive and functional deterioration evolves gradually since the onset of clinical symptoms, which may be preceded by several years or perhaps decades of silent, presymptomatic neurodegeneration. Therefore, the pharmacological treatment of AD must ideally comprise both a symptomatic effect to preserve or improve cognition and a disease-modifying effect to tackle the progression of the pathological process. Primary prevention is the ultimate goal, should these strategies be delivered to patients with preclinical AD. In this article, we briefly address the pharmaceutical compounds that are currently used for the symptomatic treatment of AD and discuss the ongoing strategies designed to modify its natural course.
Palavras-chave
Alzheimer's disease, cognitive impairment, dementia, treatment, pharmacology
URI
https://observatorio.fm.usp.br/handle/OPI/26408
Referências
  1. Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012
  2. Amanatkar HR, 2014, EXPERT REV NEUROTHER, V14, P1119, DOI 10.1586/14737175.2014.955852
  3. Annweiler C, 2012, DRUG AGING, V29, P81, DOI 10.2165/11597550-000000000-00000
  4. Birks J., 2006, COCHRANE DB SYST REV, V25, DOI 10.1002/14651858.CD005593
  5. Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4
  6. Christensen DD, 2012, POSTGRAD MED, V124, P110, DOI 10.3810/pgm.2012.11.2589
  7. Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194
  8. Cummings J., 2014, ALZH ASS INT C COP D
  9. Davis J, 2014, ADV ALZHEIMER DIS, V3, P107
  10. Devanand DP, 2014, J CLIN PSYCHIAT, V75, P775, DOI 10.4088/JCP.14ac09246
  11. Di Santo SG, 2013, J ALZHEIMERS DIS, V35, P349, DOI 10.3233/JAD-122140
  12. Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889
  13. Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951
  14. Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110
  15. Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0
  16. Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044
  17. Gauthier S, 2013, PROG NEUROBIOL, V110, P102, DOI 10.1016/j.pneurobio.2013.01.003
  18. Gauthier S, 2014, CLIN INTERV AGING, V9, P2065, DOI 10.2147/CIA.S72728
  19. Gauthier Serge, 2012, Can Geriatr J, V15, P120, DOI 10.5770/cgj.15.49
  20. Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C
  21. Grossberg GT, 2013, CNS DRUGS, V27, P469, DOI 10.1007/s40263-013-0077-7
  22. Grossberg GT, 2003, CURR THER RES CLIN E, V64, P216, DOI 10.1016/S0011-393X(03)00059-6
  23. Herrmann A, 2015, J NEUROCHEM, V132, P1, DOI 10.1111/jnc.12845
  24. Hwang SH, 2012, J ALZHEIMERS DIS, V31, P207, DOI 10.3233/JAD-2012-120439
  25. Ihl R., 1989, J NEURAL TRANSM, V1, P84
  26. Istace A., 2014, ALZH ASS INT C COP D
  27. Jack CR, 2014, NEUROLOGY, V82, P1605, DOI 10.1212/WNL.0000000000000386
  28. Kamphuis PJGH, 2011, J NUTR HEALTH AGING, V15, P720, DOI 10.1007/s12603-011-0105-6
  29. Kivipelto M, 2014, J INTERN MED, V275, P202, DOI 10.1111/joim.12193
  30. Kontsekova E., 2014, ALZHEIMERS RES THER, V6, P1
  31. Lambracht-Washington D, 2013, IMMUNOTARGETS THER, V2, P105, DOI 10.2147/ITT.S31428
  32. Landau SM, 2012, ARCH NEUROL-CHICAGO, V69, P623, DOI 10.1001/archneurol.2011.2748
  33. Landen JW, 2013, CLIN NEUROPHARMACOL, V36, P14, DOI 10.1097/WNF.0b013e31827db49b
  34. Laske C, 2014, NEW ENGL J MED, V370, P1459, DOI [10.1056/NEJMc1402193#SA1, 10.1056/NEJMc1402193]
  35. Li FJ, 2012, J ALZHEIMERS DIS, V31, P253, DOI 10.3233/JAD-2012-120349
  36. McClure R, 2015, J ALZHEIMERS DIS, V44, P283, DOI 10.3233/JAD-140798
  37. Menting KW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00165
  38. Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112
  39. Millington C., 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309129
  40. Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017
  41. Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868
  42. O'Brien JT, 2011, J PSYCHOPHARMACOL, V25, P997, DOI 10.1177/0269881110387547
  43. Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538
  44. Panza F, 2014, EXPERT REV NEUROTHER, V14, P973, DOI 10.1586/14737175.2014.945522
  45. PERRY EK, 1977, LANCET, V1, P189
  46. Recuero M, 2004, FEBS LETT, V570, P114, DOI 10.1016/j.febslet.2004.06.025
  47. Reiman EM, 2014, J CLIN PSYCHIAT, V75, P661, DOI 10.4088/JCP.14com09235
  48. Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128
  49. ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419
  50. Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839
  51. Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x
  52. Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038
  53. Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7
  54. Winblad B, 2010, J NUTR HEALTH AGING, V14, P770, DOI 10.1007/s12603-010-0122-x
  55. Winblad B, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt237
  56. Zhao L, 2013, MOLECULES, V18, P9949, DOI 10.3390/molecules18089949

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/27
Artigos e Materiais de Revistas Científicas - ODS/03